These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 31629422

  • 1. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
    Pritchard CC.
    Can J Urol; 2019 Oct; 26(5 Suppl 2):24-26. PubMed ID: 31629422
    [Abstract] [Full Text] [Related]

  • 2. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.
    J Natl Compr Canc Netw; 2019 May 01; 17(5):515-521. PubMed ID: 31085765
    [Abstract] [Full Text] [Related]

  • 3. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S, Salami SS, Spratt DE, Kaffenberger SD, Jacobs MF, Morgan TM.
    J Urol; 2019 Aug 01; 202(2):223-230. PubMed ID: 30730411
    [Abstract] [Full Text] [Related]

  • 4. Genetically Informed Prostate Cancer Treatment for Metastatic Disease.
    Siebert AL, Szymaniak BM, Numan Y, Morgans AK.
    Urol Clin North Am; 2021 Aug 01; 48(3):365-371. PubMed ID: 34210491
    [Abstract] [Full Text] [Related]

  • 5. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B.
    Cancer; 2018 Aug 01; 124(15):3105-3117. PubMed ID: 29669169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P, Silberstein JL, Markowski MC, Luo J, Lotan TL, Isaacs WB, Antonarakis ES.
    Prostate; 2018 Apr 01; 78(5):401-407. PubMed ID: 29368341
    [Abstract] [Full Text] [Related]

  • 11. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine.
    Marino F, Totaro A, Gandi C, Bientinesi R, Moretto S, Gavi F, Pierconti F, Iacovelli R, Bassi P, Sacco E.
    Prostate Cancer Prostatic Dis; 2023 Dec 01; 26(4):655-664. PubMed ID: 36434163
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S, Giri VN.
    Eur Urol Oncol; 2021 Feb 01; 4(1):1-9. PubMed ID: 33390340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Germline Testing in Prostate Cancer: When and Who to Test.
    Sokolova A, Cheng H.
    Oncology (Williston Park); 2021 Oct 20; 35(10):645-653. PubMed ID: 34669358
    [Abstract] [Full Text] [Related]

  • 17. Germline pathogenic variants in unselected Korean men with prostate cancer.
    So MK, Ahn HK, Huh J, Kim KH.
    Investig Clin Urol; 2022 May 20; 63(3):294-300. PubMed ID: 35534218
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S, Cardoso M, Paulo P, Pinheiro M, Pinto P, Santos C, Pinto C, Peixoto A, Henrique R, Teixeira MR.
    Fam Cancer; 2016 Jan 20; 15(1):111-21. PubMed ID: 26289772
    [Abstract] [Full Text] [Related]

  • 20. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH, Pritchard CC, Montgomery B, Lin DW, Nelson PS.
    Clin Genitourin Cancer; 2017 Dec 20; 15(6):625-628. PubMed ID: 28697982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.